Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist, ...

In this rapidly growing digital era, healthcare is witnessing an unprecedented transformation through artificial intelligence ...

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic ...

High genetic susceptibility to type 2 diabetes is associated with higher atherosclerotic cardiovascular disease risk and ≤1 h/d of television viewing has substantially lower risk of atherosclerotic ...

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying levels of genetic risk for Type 2 diabetes, including ...

An Australian medical technology company, Proteomics International, has published a study demonstrating a new blood test ...

Abbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business environment continues to be challenging globally. The stock carries a Zacks Rank ...

Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure -- because of the cancer ...

Argentina diabetes devices market was valued at US$ 539.12 million in 2024 and is projected to hit the market valuation of US$ 1,031.89 million by 2033 at a CAGR of 7.48% during the forecast period ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...

What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a ...